• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在存在多种疾病的情况下估算疾病间的健康成本分配

Estimating Health Cost Repartition Among Diseases in the Presence of Multimorbidity.

作者信息

Rousson Valentin, Rossel Jean-Benoît, Eggli Yves

机构信息

Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.

出版信息

Health Serv Res Manag Epidemiol. 2019 Dec 3;6:2333392819891005. doi: 10.1177/2333392819891005. eCollection 2019 Jan-Dec.

DOI:10.1177/2333392819891005
PMID:31832489
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6891012/
Abstract

We consider the nontrivial problem of estimating the health cost repartition among different diseases in the common case where the patients may have multiple diseases. To tackle this problem, we propose to use an iterative proportional repartition (IPR) algorithm, a nonparametric method which is simple to understand and to implement, allowing (among other) to avoid negative cost estimates and to retrieve the total health cost by summing up the estimated costs of the different diseases. This method is illustrated with health costs data from Switzerland and is compared in a simulation study with other methods such as linear regression and general linear models. In the case of an additive model without interactions between disease costs, a situation where the truth is clearly defined such that the methods can be compared on an objective basis, the IPR algorithm clearly outperformed the other methods with respect to efficiency of estimation in all the settings considered. In the presence of interactions, the situation is more complex and will deserve further investigation.

摘要

我们考虑在患者可能患有多种疾病的常见情况下,估计不同疾病间医疗费用分配这一重要问题。为解决此问题,我们建议使用迭代比例分配(IPR)算法,这是一种非参数方法,易于理解和实施,(除其他优点外)能够避免出现负的费用估计,并通过汇总不同疾病的估计费用来得出总医疗费用。该方法通过瑞士的医疗费用数据进行说明,并在模拟研究中与其他方法(如线性回归和一般线性模型)进行比较。在疾病费用之间不存在交互作用的加性模型情况下(这种情况下事实明确,可在客观基础上对方法进行比较),在所有考虑的设置中,就估计效率而言,IPR算法明显优于其他方法。在存在交互作用的情况下,情况更为复杂,值得进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9df2/6891012/740110517d76/10.1177_2333392819891005-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9df2/6891012/0007fb7c73e6/10.1177_2333392819891005-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9df2/6891012/bafcef9bea12/10.1177_2333392819891005-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9df2/6891012/2adce02d10f2/10.1177_2333392819891005-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9df2/6891012/740110517d76/10.1177_2333392819891005-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9df2/6891012/0007fb7c73e6/10.1177_2333392819891005-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9df2/6891012/bafcef9bea12/10.1177_2333392819891005-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9df2/6891012/2adce02d10f2/10.1177_2333392819891005-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9df2/6891012/740110517d76/10.1177_2333392819891005-fig4.jpg

相似文献

1
Estimating Health Cost Repartition Among Diseases in the Presence of Multimorbidity.在存在多种疾病的情况下估算疾病间的健康成本分配
Health Serv Res Manag Epidemiol. 2019 Dec 3;6:2333392819891005. doi: 10.1177/2333392819891005. eCollection 2019 Jan-Dec.
2
A comparison of statistical methods for allocating disease costs in the presence of interactions.存在相互作用时分配疾病成本的统计方法比较。
Stat Med. 2021 Jun 30;40(14):3286-3298. doi: 10.1002/sim.8950. Epub 2021 Apr 11.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Multimorbidity, health care utilization and costs in an elderly community-dwelling population: a claims data based observational study.老年社区居住人群的多重疾病、医疗保健利用及费用:一项基于索赔数据的观察性研究。
BMC Health Serv Res. 2015 Jan 22;15:23. doi: 10.1186/s12913-015-0698-2.
5
Modeling the Economic Impact of Interventions for Older Populations with Multimorbidity: A Method of Linking Multiple Single-Disease Models.建模多病共存的老年人群干预措施的经济影响:一种链接多个单病种模型的方法。
Med Decis Making. 2019 Oct;39(7):842-856. doi: 10.1177/0272989X19868987. Epub 2019 Aug 20.
6
Estimating health spending associated with chronic multimorbidity in 2018: An observational study among adults in the United States.估算 2018 年与慢性多病共存相关的卫生支出:美国成年人的一项观察性研究。
PLoS Med. 2023 Apr 4;20(4):e1004205. doi: 10.1371/journal.pmed.1004205. eCollection 2023 Apr.
7
The disease burden of multimorbidity and its interaction with educational level.多种疾病负担及其与教育水平的相互作用。
PLoS One. 2020 Dec 3;15(12):e0243275. doi: 10.1371/journal.pone.0243275. eCollection 2020.
8
Costs of multimorbidity: a systematic review and meta-analyses.共病的成本:系统评价和荟萃分析。
BMC Med. 2022 Jul 19;20(1):234. doi: 10.1186/s12916-022-02427-9.
9
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
10
Estimating Joint Health Condition Utility Values.估算关节健康状况效用值。
Value Health. 2019 Apr;22(4):482-490. doi: 10.1016/j.jval.2018.09.2843. Epub 2019 Feb 22.

引用本文的文献

1
Early vs. late treatment initiation in multiple sclerosis and its impact on cost of illness: A register-based prospective cohort study in Sweden.多发性硬化症早期与晚期开始治疗及其对疾病成本的影响:瑞典一项基于登记的前瞻性队列研究。
Mult Scler J Exp Transl Clin. 2022 Apr 24;8(2):20552173221092411. doi: 10.1177/20552173221092411. eCollection 2022 Apr-Jun.

本文引用的文献

1
A comparison of statistical methods for allocating disease costs in the presence of interactions.存在相互作用时分配疾病成本的统计方法比较。
Stat Med. 2021 Jun 30;40(14):3286-3298. doi: 10.1002/sim.8950. Epub 2021 Apr 11.
2
The determinants of individual health care expenditures in prison: evidence from Switzerland.监狱中个人医疗保健支出的决定因素:来自瑞士的证据。
BMC Health Serv Res. 2018 Mar 7;18(1):160. doi: 10.1186/s12913-018-2962-8.
3
The Economic Burden of Asthma in the United States, 2008-2013.美国 2008-2013 年哮喘经济负担
Ann Am Thorac Soc. 2018 Mar;15(3):348-356. doi: 10.1513/AnnalsATS.201703-259OC.
4
A Review on Methods of Risk Adjustment and their Use in Integrated Healthcare Systems.风险调整方法及其在综合医疗系统中的应用综述
Int J Integr Care. 2016 Oct 26;16(4):4. doi: 10.5334/ijic.2500.
5
A quasi-Monte-Carlo comparison of parametric and semiparametric regression methods for heavy-tailed and non-normal data: an application to healthcare costs.重尾和非正态数据的参数与半参数回归方法的拟蒙特卡罗比较:医疗成本应用
J R Stat Soc Ser A Stat Soc. 2016 Oct;179(4):951-974. doi: 10.1111/rssa.12141. Epub 2015 Oct 15.
6
Multimorbidity in chronic disease: impact on health care resources and costs.慢性病中的多重疾病:对医疗资源和成本的影响。
Risk Manag Healthc Policy. 2016 Jul 5;9:143-56. doi: 10.2147/RMHP.S97248. eCollection 2016.
7
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.1990年至2013年188个国家301种急慢性疾病和损伤的全球、区域及国家发病率、患病率和伤残调整生命年:全球疾病负担研究2013的系统分析
Lancet. 2015 Aug 22;386(9995):743-800. doi: 10.1016/S0140-6736(15)60692-4. Epub 2015 Jun 7.
8
Effects and repercussions of local/hospital-based health technology assessment (HTA): a systematic review.基于本地/医院的卫生技术评估(HTA)的效果与影响:一项系统综述
Syst Rev. 2014 Oct 28;3:129. doi: 10.1186/2046-4053-3-129.
9
Economic burden of chronic obstructive pulmonary disease.慢性阻塞性肺疾病的经济负担。
Respirology. 2012 Jan;17(1):120-6. doi: 10.1111/j.1440-1843.2011.02073.x.
10
Economic costs attributable to smoking in China: update and an 8-year comparison, 2000-2008.中国归因于吸烟的经济成本:更新与 2000-2008 年 8 年比较。
Tob Control. 2011 Jul;20(4):266-72. doi: 10.1136/tc.2010.042028. Epub 2011 Feb 21.